Jeff Errington
Prof Jeff Errington FMedSci FRS has spent much of his research career studying fundamental questions about the structure and function of bacterial cells. During 25 years at the University of Oxford, latterly as Professor of Microbiology at the Sir William Dunn School of Pathology, he made important contributions to our understanding of the molecular biology underpinning endospore formation in Bacillus subtilis.
More recently he has contributed substantially to our understanding of chromosome replication and segregation, cell division and cell morphogenesis in bacteria. His lab was one of the pioneers in the application of digital fluorescence imaging methods to bacteria. He was founder and Director of the Centre for Bacterial Cell Biology at Newcastle University in the UK, which was the world’s first major research centre focused specifically on the molecular and cellular biology of bacterial cells. On July 1st he moved to the University of Sydney with an Australian Laureate Fellowship, to continue and expand his work on L-form bacteria.
Errington’s contributions to basic science have been recognized by election to various learned societies, including Fellowship of the Royal Society, EMBO, the UK Academy of Medical Sciences and both the European and American Academies of Microbiology. He has also founded two successful spin out companies, Prolysis Ltd, and Demuris Ltd, which was recently acquired by US-based Odyssey Therapeutics.
Abstracts this author is presenting: